Showing results (71-80 of 6,842) with videos related to
Sort By:
Pageof 685
Journal of Managed Care Pharmacy : JMCP|November 6, 2008
Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999Jennifer A Palmer, Alison R Timm, Peter J NeumannAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2020
Preparing the health-care system to pay for new Alzheimer's drugsPei-Jung Lin, Joshua T Cohen, Peter J NeumannInternational Journal of Technology Assessment in Health Care|September 28, 2004
Cross-national comparison of technology assessment processesAnna García-Altés, Silvia Ondategui-Parra, Peter J NeumannHealth Affairs (Project Hope)|June 5, 2013
Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remainJames D Chambers, Katherine E May, Peter J NeumannValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 13, 2022
The History and Future of the "ISPOR Value Flower": Addressing Limitations of Conventional Cost-Effectiveness AnalysisPeter J Neumann, Louis P Garrison, Richard J WillkePediatric Neurology|October 23, 2016
Willingness to Pay for a Newborn Screening Test for Spinal Muscular AtrophyPei-Jung Lin, Wei-Shi Yeh, Peter J NeumannValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Understanding the medical and nonmedical value of diagnostic testingDavid W Lee, Peter J Neumann, John A RizzoHealth Affairs (Project Hope)|November 11, 2008
Medicare's national coverage decisions for technologies, 1999-2007Peter J Neumann, Maki S Kamae, Jennifer A PalmerThe American Journal of Managed Care|August 20, 2016
The impact of formulary drug exclusion policies on patients and healthcare costsJames D Chambers, Pallavi B Rane, Peter J NeumannValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P GarrisonPageof 685